Not Yet RecruitingNot Applicable

Dementia and Storytelling in Vietnam

Vietnam100 participantsStarted 2026-10-01

Plain-language summary

This project aims to improve knowledge regarding Alzheimer's dementia and related dementias (ADRD) among older adults and their caregivers in Vietnam and promote the early diagnosis of ADRD using a digital storytelling intervention.

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Older adults (age ≥ 60 years) residing in one of the four participating communities (communities in rural areas of Phu Tho province with minimum distance of 10 km between participating communities) * Concern about mild cognitive impairment expressed by the participant, caregiver, or healthcare provider, with no formal screening for ADRD * Ability and willingness to provide informed consent * Caregivers of eligible participants will be invited to participate after providing written consent. Exclusion Criteria: * Current participation in another ADRD study * Severe cognitive impairment as evaluated by study co-investigators * Enrollment in palliative care or diagnosis of a terminal illness * Previous exposure to digital storytelling modules * Prior participation in the digital storytelling development.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Intervention Feasibility: Participant Recruitment and Retention

Timeframe: Baseline, Month 3, Month 6

Intervention Engagement: Interaction Records from CIAS

Timeframe: Month 3, Month 6

Intervention Engagement: Exit Interview

Timeframe: Month 6

Intervention Acceptability: System Usability Scale (SUS)

Timeframe: Month 3, Month 6

ADRD Knowledge: Dementia Knowledge Assessment Scale (DKAS)

Timeframe: Baseline, Month 3, Month 6

Attitudes: Dementia Attitude Scale (DAS)

Timeframe: Baseline, Month 3, Month 6

Trial details

NCT IDNCT07431528

SponsorUniversity of Massachusetts, Worcester

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-10-31

Contact for this trial

Hoa Nguyen, PhD

508-856-8999 hoa.nguyen@umassmed.edu

View on ClinicalTrials.gov More Alzheimer Dementia (AD) trials

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Intervention Feasibility: Participant Recruitment and Retention

Timeframe: Baseline, Month 3, Month 6

Intervention Engagement: Interaction Records from CIAS

Timeframe: Month 3, Month 6

Intervention Engagement: Exit Interview

Timeframe: Month 6

Intervention Acceptability: System Usability Scale (SUS)

Timeframe: Month 3, Month 6

ADRD Knowledge: Dementia Knowledge Assessment Scale (DKAS)

Timeframe: Baseline, Month 3, Month 6

Attitudes: Dementia Attitude Scale (DAS)

Timeframe: Baseline, Month 3, Month 6